Literature DB >> 3536584

Pressure diuresis mechanism in the control of renal function and arterial pressure.

R J Roman.   

Abstract

Precise knowledge of the interrelationships between arterial pressure and urinary excretion of sodium and water is crucial to understanding the long-term control of arterial pressure. Although increases in renal perfusion pressure have been known for more than 35 years to inhibit tubular reabsorption, the mechanism of this pressure diuresis response, the humoral or physical factors involved, and even the nephron segments in which the changes in tubular function occur remain relatively unknown. This review focuses on the experimental evidence that supports current hypotheses concerning the mechanism of pressure diuresis. Specifically, it examines the possibility that pressure diuresis is caused by a small increase in glomerular filtration rate, alterations in the humoral or physical factors regulating proximal tubular reabsorption, and/or inhibition of tubular reabsorption in deep nephrons secondary to changes in hemodynamics in juxtamedullary nephrons. The concept originally proposed that the kidney serves as the dominant long-term controller of arterial pressure is largely based on the assumptions that the pressure diuresis phenomenon exists and that it occurs via a nonadaptive mechanism. It has been proposed that hypertension can develop only if the relationship between arterial pressure and sodium excretion is shifted toward higher pressures. The remainder of this review examines recent evidence indicating that an abnormality in the pressure natriuresis relationship may be associated with the development of hypertension in humans and in the genetic rat models of the disease.

Entities:  

Mesh:

Year:  1986        PMID: 3536584

Source DB:  PubMed          Journal:  Fed Proc        ISSN: 0014-9446


  8 in total

Review 1.  Proximal nephron.

Authors:  Jia L Zhuo; Xiao C Li
Journal:  Compr Physiol       Date:  2013-07       Impact factor: 9.090

2.  Proximal Tubule-Specific Deletion of the NHE3 (Na+/H+ Exchanger 3) Promotes the Pressure-Natriuresis Response and Lowers Blood Pressure in Mice.

Authors:  Xiao C Li; Manoocher Soleimani; Dongmin Zhu; Isabelle Rubera; Michel Tauc; Xiaowen Zheng; Jianfeng Zhang; Xu Chen; Jia L Zhuo
Journal:  Hypertension       Date:  2018-12       Impact factor: 10.190

3.  Vasopressin-induced natriuresis in the conscious rat: role of blood pressure, renal prostaglandin synthesis and the peptide ANF.

Authors:  C J Lote; A Thewles; J A Wood
Journal:  J Physiol       Date:  1989-04       Impact factor: 5.182

4.  Reinforcing feedback loop of renal cyclic guanosine 3' 5' -monophosphate and interstitial hydrostatic pressure in pressure-natriuresis.

Authors:  David C Lieb; Brandon A Kemp; Nancy L Howell; John J Gildea; Robert M Carey
Journal:  Hypertension       Date:  2009-10-19       Impact factor: 10.190

5.  Acute angiotensin II infusions elicit pressure natriuresis in mice and reduce distal fractional sodium reabsorption.

Authors:  Di Zhao; L Gabriel Navar
Journal:  Hypertension       Date:  2008-05-26       Impact factor: 10.190

Review 6.  Recent Updates on the Proximal Tubule Renin-Angiotensin System in Angiotensin II-Dependent Hypertension.

Authors:  Xiao C Li; Jia L Zhuo
Journal:  Curr Hypertens Rep       Date:  2016-08       Impact factor: 5.369

Review 7.  Intratubular, Intracellular, and Mitochondrial Angiotensin II/AT1 (AT1a) Receptor/NHE3 Signaling Plays a Critical Role in Angiotensin II-Induced Hypertension and Kidney Injury.

Authors:  Xiao Chun Li; Chih-Hong Wang; Ana Paula Oliveira Leite; Jia Long Zhuo
Journal:  Front Physiol       Date:  2021-08-02       Impact factor: 4.566

8.  Albuminuria indicates the pressure-associated injury of juxtamedullary nephrons and cerebral strain vessels in spontaneously hypertensive stroke-prone rats.

Authors:  Tasuku Nagasawa; Takefumi Mori; Yusuke Ohsaki; Yoshimi Yoneki; Qi Guo; Emiko Sato; Ikuko Oba; Sadayoshi Ito
Journal:  Hypertens Res       Date:  2012-08-23       Impact factor: 3.872

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.